Member Access

Registration is free


Kinase Drug Discovery (Rsc Drug Discovery)

by Richard A. Ward, Frederick Goldberg, David P. Rotella and David E. Thurston


Available in Dec 2011.

Visit our bookshelf for more books on Kinases and Kinase Inhibitors or pre-order this book today

B&W Powered

Welcome to the Kinase Data Portal
PDF Print E-mail

Untitled Document


====== WATCH A DEMO ======

Last Updated on Thursday, 03 May 2012 05:47
Eidogen-Sertanty to release Oncology Database PDF Print E-mail
Written by Administrator   
Tuesday, 30 August 2011 06:10

PRESS RELEASE: San Diego, CA (August 22, 2011) – Eidogen-Sertanty, Inc. has announced a new oncology knowledgebase focusing on emerging and hot targets. Complementing its flagship Kinase Knowledgebase (KKB), Eidogen-Sertanty's Oncology Knowledgebase (OKB) focuses on a broad spectrum of targets relevant to Colon cancer, Esophageal cancer, Glioma, Head and Neck cancer, Kidney cancer, Leukemia, Liver cancer, Lung cancer, Lymphoma, Melanoma, Ovarian cancer, Prostate cancer, Skin cancer, and Stomach cancer.

Last Updated on Tuesday, 30 August 2011 20:17
The Kinase Knowledgebase or "KKB" PDF Print E-mail
Written by Administrator   
Friday, 12 August 2011 19:44

The Kinase Knowledgebase (KKB) is an Eidogen-Sertanty's database of kinase structure-activity and chemical synthesis data (register to download a free sample dataset in IJC or SDF format). The KKB represents the first gene-family wide implementation of our proprietary web-based technology for the capture, curation, and display of biological activity and chemical synthesis data from scientific literature and patent. Kinase Knowledgebase (KKB™), a small molecule activity data is manually curated by a experienced team of PhD chemists and biologists from patents and peer-reviewed publications.

Last Updated on Saturday, 20 August 2011 22:54
Live Webinar Series PDF Print E-mail
Written by Administrator   
Sunday, 14 August 2011 08:19

Aug 3rd, Sep 14 and Oct 19: "Utilizing Kinase Inhibition Data  from Journal Articles and Patents in your Research". 

Protein kinases are now one of the most intensely pursued classes of drug targets. Over 30 distinct kinase targets and over 200 kinase inhibitors are in clinical development. While currently most of the clinical kinase drug targets are being investigated for treatment of cancer, a growing number of other disorders including immunological, neurological, metabolic and infectious diseases, have been associated with dysregulation of protein phosphorylation. 

Last Updated on Tuesday, 25 October 2011 22:26
Kinome on the go! PDF Print E-mail
Written by Administrator   
Friday, 12 August 2011 17:54

iKinase and iKinasePro are our mobile apps that provide access into Eidogen-Sertanty's Kinase Knowledgebase. The iKinase app runs on Apple iPhone devices. The Pro version runs on Apple iPhone as well as iPad devices. Expanding from iKinase, iKinasePro provides access into Eidogen-Sertanty's Kinase Knowledgebase (KKB) with fast and powerful substructure-, similarity-, and super-similarity searching capability.

Last Updated on Sunday, 14 August 2011 08:18
Copyright © 2015 Kinase Data Portal. All Rights Reserved.

KinaseData Forum Latest Posts

No posts to display.

Latest Tweets

Featured Links:

B&W Powered

Fight Against Cancer